Can Bespoke Analytics Put New Dazzle On Copy Drugs?
Start-up Picket Pharmaceuticals Plots A Data-Centric Course To Success In The Disorderly US Generics Market
Executive Summary
Disruptions in the supply/demand configuration of generic drugs have plagued US health care for years. Picket Pharmaceuticals, a new start-up founded by a biostatistician veteran of Africa’s war on HIV, is using the illuminating powers of big data to stabilize the generics supply chain and find untapped areas of value among thousands of products in a business that remains a mystery to physicians, payers and patients alike.